Literature DB >> 21050163

Advances in whole genome sequencing technology.

Jianhua Zhao1, Struan F A Grant.   

Abstract

Sanger sequencing revolutionized the field of genetics by becoming the standard approach to appraise a given region of the genome at base-level resolution. However, the relatively recent need to sequence entire genomes has driven innovative developments within the market-place to allow for sequencing technology to be faster, cheaper and more accurate. In this review, we will cover these recent developments from both a technical and cost perspective. Firstly, we will place sequencing in a historical context by describing how it first came to the attention of the scientific community. Next, we will address the current high-throughput technologies generally available, including Roche's 454, Illumina's Genome Analyzer, Applied BioSystem's SOLiD, Complete Genomics, Helios, Pacific Biosciences and IonTorrent. These 'next-generation' technologies also allow for applications related to target region deep sequencing, epigenetics(ChIP-seq), transcriptome sequencing (RNA-seq), megagenomics. Thus, these technologies offer unprecedented opportunities to increase our understanding of the functions and dynamics of the human genome in the near future.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21050163     DOI: 10.2174/138920111794295729

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  22 in total

1.  Epigenetics in the human brain.

Authors:  Isaac Houston; Cyril J Peter; Amanda Mitchell; Juerg Straubhaar; Evgeny Rogaev; Schahram Akbarian
Journal:  Neuropsychopharmacology       Date:  2012-05-30       Impact factor: 7.853

Review 2.  Next-generation sequencing reveals the secrets of the chronic lymphocytic leukemia genome.

Authors:  Andrew J Ramsay; Alejandra Martínez-Trillos; Pedro Jares; David Rodríguez; Agnieszka Kwarciak; Víctor Quesada
Journal:  Clin Transl Oncol       Date:  2012-08-22       Impact factor: 3.405

3.  Comparison of data acquisition strategies on quadrupole ion trap instrumentation for shotgun proteomics.

Authors:  Jesse D Canterbury; Gennifer E Merrihew; Michael J MacCoss; David R Goodlett; Scott A Shaffer
Journal:  J Am Soc Mass Spectrom       Date:  2014-09-27       Impact factor: 3.109

Review 4.  The future of neuroepigenetics in the human brain.

Authors:  Amanda Mitchell; Panos Roussos; Cyril Peter; Nadejda Tsankova; Schahram Akbarian
Journal:  Prog Mol Biol Transl Sci       Date:  2014       Impact factor: 3.622

5.  Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target.

Authors:  Colin C Collins; Stanislav V Volik; Anna V Lapuk; Yuwei Wang; Peter W Gout; Chunxiao Wu; Hui Xue; Hongwei Cheng; Anne Haegert; Robert H Bell; Sonal Brahmbhatt; Shawn Anderson; Ladan Fazli; Antonio Hurtado-Coll; Mark A Rubin; Francesca Demichelis; Himisha Beltran; Martin Hirst; Marco Marra; Christopher A Maher; Arul M Chinnaiyan; Martin Gleave; Joseph R Bertino; Martin Lubin; Yuzhuo Wang
Journal:  Mol Cancer Ther       Date:  2012-01-17       Impact factor: 6.261

Review 6.  The cancer antigenome.

Authors:  Bianca Heemskerk; Pia Kvistborg; Ton N M Schumacher
Journal:  EMBO J       Date:  2012-12-21       Impact factor: 11.598

Review 7.  Microfluidic technologies for accelerating the clinical translation of nanoparticles.

Authors:  Pedro M Valencia; Omid C Farokhzad; Rohit Karnik; Robert Langer
Journal:  Nat Nanotechnol       Date:  2012-10       Impact factor: 39.213

8.  Public knowledge of and attitudes toward genetics and genetic testing.

Authors:  Susanne B Haga; William T Barry; Rachel Mills; Geoffrey S Ginsburg; Laura Svetkey; Jennifer Sullivan; Huntington F Willard
Journal:  Genet Test Mol Biomarkers       Date:  2013-02-13

9.  Managing Expectational Language: Translational genetic professionals consider the clinical potential of next-generation sequencing technologies.

Authors:  Pei P Koay; Richard R Sharp
Journal:  New Genet Soc       Date:  2014-06-01

10.  A systematic comparison and evaluation of high density exon arrays and RNA-seq technology used to unravel the peripheral blood transcriptome of sickle cell disease.

Authors:  Nalini Raghavachari; Jennifer Barb; Yanqin Yang; Poching Liu; Kimberly Woodhouse; Daniel Levy; Christopher J O'Donnell; Peter J Munson; Gregory J Kato
Journal:  BMC Med Genomics       Date:  2012-06-29       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.